Observational Study
Copyright ©The Author(s) 2021.
World J Gastroenterol. Dec 7, 2021; 27(45): 7831-7843
Published online Dec 7, 2021. doi: 10.3748/wjg.v27.i45.7831
Table 3 Clinical characteristics associated with in-hospital mortality
Characteristics Univariable analysis
Multivariable analysis
Unadjusted OR (95%CI)
P value
Adjusted OR (95%CI)
P value
Female sex0.96 (0.85-1.09)0.520.91 (0.78-1.07)0.27
Age (yr)
18-391 (ref)-1 (ref)-
40-591.21 (0.91-1.60)0.191.45 (1.28-1.64)< 0.001
60-791.24 (0.93-1.65)0.141.77 (1.68-1.87)< 0.001
≥ 801.68 (1.17-2.42)0.0052.12 (1.51-3.00)< 0.001
Race
White1 (ref)-1 (ref)-
Black1.38 (1.11-1.71)0.0031.26 (0.91-1.75)0.16
Hispanic1.05 (0.86-1.29)0.611.12 (0.78-1.61)0.53
Asian/Pacific Islander1.44 (0.91-2.27)0.121.30 (0.98-1.73)0.07
Native American1.04 (0.59-1.84)0.881.11 (0.86-1.43)0.43
Other0.88 (0.59-1.32)0.550.93 (0.48-1.81)0.84
Weekend admission1.14 (0.98-1.32)0.081.05 (0.82-1.34)0.69
Liver disease etiology
Alcohol-related0.90 (0.80-1.01)0.080.85 (0.71-1.01)0.06
Viral hepatitis 0.98 (0.86-1.13)0.831.00 (0.81-1.24)1.00
Comorbidities
Smoking 0.96 (0.79-1.16)0.661.15 (0.83-1.60)0.40
Alcohol use0.98 (0.87-1.11)0.791.35 (1.26-1.45)< 0.001
Drug use0.84 (0.62-1.14)0.260.77 (0.55-1.08)0.13
HIV/AIDS1.02 (0.51-2.07)0.950.81 (0.58-1.13)0.22
Autoimmune arthritis1.10 (0.64-1.91)0.731.14 (0.54-2.41)0.72
Congestive heart failure1.05 (0.88-1.26)0.590.99 (0.87-1.12)0.84
Chronic pulmonary disease1.00 (0.84-1.21)0.960.95 (0.78-1.16)0.63
Coagulopathy1.01 (0.90-1.15)0.821.15 (1.16-1.25)0.001
Diabetes mellitus0.78 (0.67-0.89)< 0.0010.87 (0.73-1.04)0.12
Hypertension0.76 (0.67-0.86)< 0.0010.83 (0.70-1.01)0.06
Lymphoma1.42 (0.68-2.96)0.351.53 (0.42-5.60)0.52
Fluid/electrolyte disorders0.85 (0.74-0.97)0.020.87 (0.75-1.01)0.07
Cancer1.34 (1.13-1.59)0.0011.40 (0.88-2.23)0.15
Neurological disorders1.29 (0.98-1.70)0.071.38 (1.21-1.58)< 0.001
Obesity0.87 (0.70-1.07)0.200.92 (0.62-1.38)0.70
Peripheral vascular disorders0.78 (0.51-1.18)0.230.78 (0.42-1.46)0.44
Psychoses0.80 (0.55-1.16)0.240.93 (0.78-1.12)0.44
Pulmonary circulation disorders0.75 (0.53-1.05)0.100.68 (0.43-1.08)0.11
Valvular disease0.75 (0.53-1.07)0.121.01 (0.64-1.60)0.96
Weight loss0.91 (0.78-1.07)0.271.05 (0.97-1.13)0.21
Medical procedure
Renal replacement therapy0.98 (0.85-1.14)0.810.92 (0.68-1.25)0.59
Liver transplantation0.33 (0.23-0.46)< 0.0010.15 (0.11-0.21)< 0.001
TIPS0.40 (0.18-0.90)0.030.23 (0.12-0.43)< 0.001
Paracentesis0.46 (0.41-0.53)< 0.0010.48 (0.43-0.53)< 0.001
Mechanical ventilation6.97 (5.66-8.59)< 0.0019.24 (7.90-10.81)< 0.001

  • Citation: Kaewput W, Thongprayoon C, Dumancas CY, Kanduri SR, Kovvuru K, Kaewput C, Pattharanitima P, Petnak T, Lertjitbanjong P, Boonpheng B, Wijarnpreecha K, Zabala Genovez JL, Vallabhajosyula S, Jadlowiec CC, Qureshi F, Cheungpasitporn W. In-hospital mortality of hepatorenal syndrome in the United States: Nationwide inpatient sample. World J Gastroenterol 2021; 27(45): 7831-7843
  • URL: https://www.wjgnet.com/1007-9327/full/v27/i45/7831.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v27.i45.7831